«According to Søren Smed Østergaard, Vice President, Digital Health of Novo Nordisk, the most significant innovations in the diabetes space centered around hardware, artificial intelligence (AI) and data. He believes that having access to more accurate data on individual behavior and medication usage could positively impact people living with diabetes.»

«»We know there is a huge discrepancy between how people should use medication and how they’re using it,» said Østergaard. «In 2003, the World Health Organisation (WHO) said improving medication adherence will have a more significant impact on the population’s health than improvements to specific medical treatments.»

Article written by Jennifer Kite-Powell